Company: CERO
Filing Date: 2025-07-21
Form Type: S-1
Source: 0001213900-25-066152
Chunk: 11

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-07-21
Form: S-1
Chunk 11
---
 Agreement” refers to the Registration Rights Agreement, dated as of March 29, 2024, by and between CERo and certain PIPE Investors. “Second Securities Purchase Agreement” refers to the Securities Purchase Agreement, dated as of March 29, 2024, by and among CERo and certain PIPE Investors, pursuant to which CERo agreed to issue and sell 626 shares of Series B Preferred Stock. viii “ Securities Act” refers to the Securities Act of 1933, as amended. “ Securities Purchase Agreements” refers to the First Securities Purchase Agreement, the Second Securities Purchase Agreement and the Third Securities Purchase Agreement. “ Selling Securityholder”refers to Keystone. “ Series A Certificate of Designations” refers to the Certificate of Designations of Rights and Preferences of the Series A Preferred Stock, as amended from time to time. “ Series A Preferred Stock” refers to the Series A convertible preferred stock, $0.0001 par value per share, of CERo. “ Series A Warrants” refers to warrants to purchase Common Stock, at a current exercise price of $2,780.00 per share, sold to certain PIPE Investors pursuant to the First Securities Purchase Agreement. “ Series B Certificate of Designations” refers to the Certificate of Designations of Rights and Preferences of the Series B Preferred Stock, as amended from time to time. “ Series B Preferred Stock” refers to the Series B convertible preferred stock, $0.0001 par value per share, of CERo. “ Series C Certificate of Designations” refers to the Certificate of Designations of Rights and Preferences of the Series C Preferred Stock, as amended from time to time. “ Series C Preferred Stock” refers to the Series C convertible preferred stock, $0.0001 par value per share, of CERo. “ Series C Warrants” refers to warrants to purchase shares of Common Stock, at a current exercise price of $0.80 per share, sold to certain PIPE Investors pursuant to the Third Securities Purchase Agreement. “ Series D Certificate of Designations” refers to the Certificate of Designations of Rights and Preferences of the Series D Preferred Stock, as amended from time to time. “ Series D Preferred Stock” refers to the Series D convertible preferred stock, $0.0001 par value per share, of CERo. “ Sponsor” refers to Phoenix Biotech Sponsor, LLC, a Delaware limited liability company. “ Tertiary Earnout Shares” refer to the 500 shares of Common Stock issued